Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
RFL Rafael Holdings Inc
- Stocks
- Healthcare
- NYSE: RFL
Price (delayed)
$1.45
Market cap
$36.12M
P/E Ratio
N/A
Dividend/share
$0.02
EPS
-$2.11
Enterprise value
-$9.81M
Rafael Holdings is focused on development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies, Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd. Through
Highlights
The revenue has soared by 157% YoY
Rafael Holdings's gross profit has soared by 73% YoY but it has decreased by 6% from the previous quarter
Rafael Holdings's quick ratio has shrunk by 60% YoY
The debt has grown by 41% YoY
Key stats
What are the main financial stats of RFL
Market
Valuations
Earnings
Shares outstanding
24.91M
Market cap
$36.12M
Enterprise value
-$9.81M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.52
Price to sales (P/S)
49.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-13.89
Revenue
$706,000
Gross profit
$477,000
Operating income
-$107.57M
Net income
-$50.47M
EBIT
-$52.55M
EBITDA
-$52.2M
Free cash flow
-$8.62M
Per share
Balance sheet
Liquidity
EPS
-$2.11
EPS diluted
-$2.11
Free cash flow per share
-$0.36
Book value per share
$2.81
Revenue per share
$0.03
TBVPS
$3.36
Total assets
$83.04M
Total liabilities
$10.48M
Debt
$2.39M
Equity
$69.38M
Working capital
$58.72M
Debt to equity
0.03
Current ratio
9.26
Quick ratio
9.16
Net debt/EBITDA
0.88
Margins
Efficiency
Dividend
EBITDA margin
-7,393.9%
Gross margin
67.6%
Net margin
-7,148.2%
Operating margin
-15,236.1%
Return on assets
-54.7%
Return on equity
-64.9%
Return on invested capital
-79%
Return on capital employed
-69.2%
Return on sales
-7,442.9%
Dividend yield
1.31%
DPS
$0.02
Payout ratio
N/A
RFL stock price
How has the Rafael Holdings stock price performed over time
Intraday
9.02%
1 week
-5.84%
1 month
-14.71%
1 year
-8.81%
YTD
-12.12%
QTD
-22.46%
Financial performance
How have Rafael Holdings's revenue and profit performed over time
Revenue
$706,000
Gross profit
$477,000
Operating income
-$107.57M
Net income
-$50.47M
Gross margin
67.6%
Net margin
-7,148.2%
The revenue has soared by 157% YoY
Rafael Holdings's gross profit has soared by 73% YoY but it has decreased by 6% from the previous quarter
Rafael Holdings's gross margin has decreased by 32% YoY and by 7% QoQ
The net income has declined by 27% since the previous quarter
Price vs fundamentals
How does RFL's price correlate with its fundamentals
Growth
What is Rafael Holdings's growth rate over time
Valuation
What is Rafael Holdings stock price valuation
P/E
N/A
P/B
0.52
P/S
49.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-13.89
The EPS has declined by 27% since the previous quarter
The P/B is 65% lower than the 5-year quarterly average of 1.5 and 13% lower than the last 4 quarters average of 0.6
RFL's equity is down by 32% YoY and by 6% QoQ
The revenue has soared by 157% YoY
The price to sales (P/S) is 71% lower than the 5-year quarterly average of 169.0 and 24% lower than the last 4 quarters average of 65.0
Efficiency
How efficient is Rafael Holdings business performance
The ROIC has dropped by 55% since the previous quarter
The ROE has contracted by 40% from the previous quarter
RFL's ROA is down by 35% QoQ
The return on sales has declined by 23% since the previous quarter
Dividends
What is RFL's dividend history
DPS
$0.02
Dividend yield
1.31%
Payout ratio
N/A
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Rafael Holdings financials performed over time
The total liabilities has soared by 169% YoY
Rafael Holdings's quick ratio has shrunk by 60% YoY
The debt is 97% less than the equity
Rafael Holdings's debt to equity has surged by 50% YoY
The debt has grown by 41% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.